Clinical Trial Update: Allogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating allogeneic platelet lysate eye drops for severe chronic ocular graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Graft-versus-host Disease

Drugs mentioned

• Allogeneic Platelet Lysate Eye Drops (Allogeneic platelet lysate eye drops)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Ocular Graft-versus-host Disease | Phase 2 | Status: COMPLETED